Case Study: Navigating Temporary Halts Through a Collaborative Approach Between Sponsors

Time: 1:00 pm
day: Day Two


  • Discuss the challenges presented with temporary halts on gene therapy clinical trials
  • How to successfully co-operate with regulatory agencies to renew proceedings
  • What impacts do these halts have on the patient rare disease community?
  • A collaborative approach: A mechanism to mitigate risks in gene therapy development programmes